Immunomodulators in Combined Therapy of Patients with Chronic Hepatitis

QR Code

Immunomodulators in Combined Therapy of Patients with Chronic Hepatitis

The efficacy of the use of triple schemes in combined therapy of chronic virus hepatitis was estimated and its safety was monitored. The problems of therapy of mixed hepatitis in drug addicts are discussed. Immunotropic agents, increasing the efficacy of the standard therapy of chronic affections of...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. G. Romantsov, T. V. Sologub, A. A. Shuldyakov, A. N. Bondarenko, A. L. Kovalenko
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	chronic virus hepatitis b and c cycloferon interferons immunomodulators lamivudine ribavirin adverse reactions
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/352
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rational Pharmacotherapy and Correction of Immunity Disorders in Children with Chronic Hepatitis (Clinical Review)
by: L. G. Goryacheva, et al.
Published: (2020-05-01)

Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)
by: V. V. Stelmakh, et al.
Published: (2020-05-01)

Cycloferon Efficacy of Therapy of Chronic Hepatitis B (Results of Randomized Multicentre Study)
by: T. V. Sologub, et al.
Published: (2020-05-01)

Cycloferon Therapy of Acute and Chronic Virus Hepatitis C
by: V. P. Malyy, et al.
Published: (2020-05-01)

Results of the ORION open comparative randomized trial: evaluation of efficacy of the Russian drugs Altevir and Phosphogliv in combined treatment of chronic hepatitis C
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

Iron metabolism in chronic hepatitis C patients on antiviral treatment
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Treatment for recurrent HCV infection after liver transplantation for final stages of chronic hepatitis С
by: V. E. Syutkin, et al.
Published: (2018-08-01)

Treatment of hepatitis C in liver transplant recipients in the Moscow Center for Liver Transplantation within 10 years
by: M. Sh. Khubutia, et al.
Published: (2016-01-01)

Leukopenia and neutropenia in chronic hepatitis C patients with various underlying combination antiviral therapy
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Hepatitis B and reproductive health
by: M. V. Mayevskaya
Published: (2009-10-01)

Kinetics of Virus Load HCV-RNA in Blood Serum and Peripheral Mononuclear Cells in a Patient with Hepatocirrhosis and Chronic Virus Hepatitis C Termination Treated According to Noninterferon Treatment Scheme (Cycloferon + Ribavirin)
by: V. C. Stelmah, et al.
Published: (2020-05-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

Clinical significance blood platelet count in patients with chronic hepatitis C on the background of the various options combined antiviral therapy
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

The expirience of IDEAL
by: E. Z. Burnevich
Published: (2014-09-01)

EFFICACY AND SAFETY OF THE COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON ALFA-2A IN PATIENTS WITH CHRONIC HEPATITIS C: THE RESULTS OF TWO MULTICENTER, PROSPECTIVE, OPEN, NON-COMPARATIVE CLINICAL TRIALS
by: K. V. Zhdanov, et al.
Published: (2018-01-01)

Clinical significance of anaemia in chronic hepatitis c on the combined antiviral therapy with pegylated
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Immunomodulators in Therapy of Respiratory Infections
by: V. A. Isakov, et al.
Published: (2020-05-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

Immunomodulator Intensification of Etioropic Therapy in Patients with Advanced Pulmonary Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2020-05-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

PREVALENCE OF SIDE EFFECTS OF INTERFERON THERAPY IN CHILDREN WITH CHRONIC VIRAL HEPATITIS C
by: T. A. Skvortsova, et al.
Published: (2013-05-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Evaluation of Safety and Pharmacotherapeutic Efficacy of Cycloferon in Treatment of Astrakhan Rickettsial Fever
by: YU. V. Sherysheva, et al.
Published: (2020-05-01)

The Use of Interferon Inducers in an Infectious Disease Clinic
by: A. A. Shuldyakov, et al.
Published: (2020-05-01)

Cycloferon as an Agents of Antirelpsing Therapy in Patients with Chronic Hyperplastic Sinusitis
by: I. P. Vasilenko, et al.
Published: (2020-05-01)

Cycloferon in Complex Medicamentous Management of Chronic Laryngitis
by: E. V. Demchenko, et al.
Published: (2020-05-01)

POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01)

Modern etiotropic therapy of chronic viral hepatitis B
by: E. B. Bun'kova, et al.
Published: (2024-10-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Diffuse large B-cells lymphoma clinical features in patients with hepatitis B and C infection
by: G. I. Storozhakov, et al.
Published: (2022-11-01)

The incidence of chronic viral hepatitis and the analysis of the genetic diversity of hepatitis B and C viruses among the population of Khabarovsk city
by: Valeriya O. Kotova, et al.
Published: (2025-03-01)

Immunological and Virological Responses in Patients with Monoinfection and Coinfection with Hepatitis B and C Viruses in the Brazilian Amazon
by: Joseane R. Silva, et al.
Published: (2025-06-01)

State and prospects of therapeutic treatment of children with chronic hepatitis C in the Russian Federation
by: A. A. Fomicheva, et al.
Published: (2021-03-01)

Virus Infections and Interferon Inductors in the Complex Therapy
by: M. G. Romantsov, et al.
Published: (2020-05-01)

Two ways to one goal: new strategy of antiviral therapy for chronic hepatitis C
by: S. N. Batskikh
Published: (2012-11-01)

Monitoring of Side Effects and Estimation of Cycloferon Efficacy in Treatment of Children with Frequent and Prolonged Diseases
by: S. A. Lyalikov, et al.
Published: (2020-05-01)

Cycloferon Efficiency in Children's and Adults' Hepatitis B and C Treatment: Systematic Review and Meta-Analysis Results
by: N. K. Mazina, et al.
Published: (2020-05-01)

Type 1 and Type 2 Interferon Inductor (Cycloferon) in Therapy of Children with Pyelonephritis Associated with Herpes Viruses
by: S. B. Orekhova, et al.
Published: (2020-05-01)

Genetic variants of hepatitis B virus in patients with chronic hepatitis B
by: E. A. Elpaeva, et al.
Published: (2015-11-01)

Liver cirrhosis as a result of chronic hepatitis C
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)